ZA200804266B - Therapeutic uses of steroidal compounds - Google Patents

Therapeutic uses of steroidal compounds

Info

Publication number
ZA200804266B
ZA200804266B ZA200804266A ZA200804266A ZA200804266B ZA 200804266 B ZA200804266 B ZA 200804266B ZA 200804266 A ZA200804266 A ZA 200804266A ZA 200804266 A ZA200804266 A ZA 200804266A ZA 200804266 B ZA200804266 B ZA 200804266B
Authority
ZA
South Africa
Prior art keywords
therapeutic uses
steroidal compounds
steroidal
compounds
therapeutic
Prior art date
Application number
ZA200804266A
Other languages
English (en)
Inventor
Wulfert Ernst
Murray James Robert
Wynick David
Original Assignee
Hunter Fleming Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hunter Fleming Ltd filed Critical Hunter Fleming Ltd
Publication of ZA200804266B publication Critical patent/ZA200804266B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
ZA200804266A 2005-11-18 2008-05-16 Therapeutic uses of steroidal compounds ZA200804266B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0523550.2A GB0523550D0 (en) 2005-11-18 2005-11-18 Therapeutic uses of steroidal compounds

Publications (1)

Publication Number Publication Date
ZA200804266B true ZA200804266B (en) 2009-01-28

Family

ID=35580318

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200804266A ZA200804266B (en) 2005-11-18 2008-05-16 Therapeutic uses of steroidal compounds

Country Status (16)

Country Link
US (1) US8846652B2 (xx)
EP (1) EP1948192A2 (xx)
JP (1) JP5395437B2 (xx)
KR (1) KR101314694B1 (xx)
CN (1) CN101346144B (xx)
AU (1) AU2006314226B2 (xx)
CA (1) CA2630441C (xx)
GB (1) GB0523550D0 (xx)
IL (1) IL191457A (xx)
MX (1) MX2008006440A (xx)
NO (1) NO20082741L (xx)
NZ (1) NZ568560A (xx)
RU (1) RU2427375C2 (xx)
TW (1) TWI386211B (xx)
WO (1) WO2007057691A2 (xx)
ZA (1) ZA200804266B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU20110244A7 (es) 2011-12-27 2013-08-29 Ct De Investigación Y Desarrollo De Medicamentos Cidem Sistemas espiroesteroidales con efectos neuroactivos y anti-inflamatorios
CN108434090A (zh) * 2017-02-14 2018-08-24 高药品股份有限公司 以生理脂肪为基剂的类固醇药膏
RU2745868C9 (ru) * 2020-05-28 2021-04-08 Федеральное государственное бюджетное образовательное учреждение высшего образования «Национальный исследовательский Мордовский государственный университет им. Н.П. Огарёва» Способ ускорения регенерационных процессов в поврежденных периферических нервах

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992012997A1 (en) 1991-01-16 1992-08-06 The General Hospital Corporation Human galanin
AU1462692A (en) 1991-02-25 1992-09-15 Board Of Regents Of The University Of Washington, The Methods for detecting galanin antagonists
JP3135262B2 (ja) 1991-03-06 2001-02-13 ガーヴァン インスティチュート オブ メディカル リサーチ ヒトのガラニン、ヒトのガラニンをエンコードするｃＤ ＮＡクローンとヒトのガラニン製造方法
SE9101472D0 (sv) 1991-05-15 1991-05-15 Trion Forskning & Utveckling Galanin antagonist
JPH06172387A (ja) 1992-12-11 1994-06-21 Aibaitsu Kk 合成ペプチド誘導体
AU6657894A (en) * 1993-05-18 1994-12-12 Ltt Institute Co., Ltd. Osteogenesis promoter and osteoporosis remedy
JPH09151197A (ja) * 1995-11-29 1997-06-10 L T T Kenkyusho:Kk 自己免疫疾患治療薬
EP0918455B1 (en) 1996-07-24 2003-04-16 Neurotargets Limited Use of galanin to repair nerve damage
JP2000169374A (ja) 1998-12-03 2000-06-20 Ltt Kenkyusho:Kk Ｉｇｆ増強剤
PE20010404A1 (es) 1999-06-11 2001-04-09 Watson Pharmaceuticals Inc Combinacion de esteroides androgenicos no orales y compuestos estrogenicos y su uso en mujeres
GB0105772D0 (en) * 2001-03-08 2001-04-25 Sterix Ltd Use
EP1243262B1 (en) 2001-03-20 2006-05-31 Schwarz Pharma Ag Novel use of a peptide class of compound for treating non-neuropathic inflammatory pain
WO2002096934A1 (en) 2001-05-25 2002-12-05 Kemia, Inc. Non-natural galanin receptor ligands
HUP0401110A3 (en) 2001-07-16 2012-09-28 Ortho Mcneil Pharm Inc Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
CA2451288A1 (en) 2001-07-31 2003-02-13 Pharmacia & Upjohn Company Treatment of chronic pain with 3-heterocyclyl- and 3-cycloalkyl-3-aryloxypropanamines
JP2005500344A (ja) 2001-07-31 2005-01-06 ファルマシア・アンド・アップジョン・カンパニー ３−アリールオキシ−３−フェニルプロパンアミンを用いた慢性疼痛の治療
ES2268095T3 (es) 2001-10-16 2007-03-16 Endo Pharmaceuticals Inc. Uso de carbinoles para el tratamiento de la disfuncion neuropatica.
GB0403509D0 (en) 2004-02-17 2004-03-24 Neuro Targets Ltd Galanin receptors and brain injury
GB0409498D0 (en) * 2004-04-28 2004-06-02 Hunter Fleming Ltd Transdermal steroid formulation
US20090215731A1 (en) * 2005-10-19 2009-08-27 Chavah Pty Ltd. Reduction of Side Effects From Aromatase Inhibitors Used for Treating Breast Cancer
CA2670957A1 (en) 2006-11-30 2008-06-05 Hunter-Fleming Limited Modulation of prostaglandin/cyclooxygenase metabolic pathways

Also Published As

Publication number Publication date
US20090227551A1 (en) 2009-09-10
GB0523550D0 (en) 2005-12-28
JP2009515939A (ja) 2009-04-16
TWI386211B (zh) 2013-02-21
MX2008006440A (es) 2008-12-01
WO2007057691A2 (en) 2007-05-24
IL191457A (en) 2013-10-31
RU2008124834A (ru) 2009-12-27
CA2630441A1 (en) 2007-05-24
AU2006314226B2 (en) 2012-02-02
CA2630441C (en) 2013-10-29
AU2006314226A1 (en) 2007-05-24
CN101346144B (zh) 2011-07-20
JP5395437B2 (ja) 2014-01-22
US8846652B2 (en) 2014-09-30
IL191457A0 (en) 2009-08-03
KR101314694B1 (ko) 2013-10-07
KR20080073755A (ko) 2008-08-11
NO20082741L (no) 2008-07-23
WO2007057691A3 (en) 2007-08-02
EP1948192A2 (en) 2008-07-30
RU2427375C2 (ru) 2011-08-27
CN101346144A (zh) 2009-01-14
NZ568560A (en) 2010-11-26
TW200730180A (en) 2007-08-16

Similar Documents

Publication Publication Date Title
EP2068864A4 (en) THERAPEUTIC USES OF UROLITHINS
GB0518390D0 (en) Therapeutic compounds
GB0610680D0 (en) Therapeutic compounds
GB0518237D0 (en) Therapeutic compounds
IL193678A0 (en) Therapeutic compounds
GB0509326D0 (en) Therapeutic compounds
GB0509573D0 (en) Therapeutic compounds
GB0603041D0 (en) Therapeutic compounds
HK1203925A1 (en) Therapeutic compounds
GB0518361D0 (en) Therapeutic compounds
GB0522881D0 (en) Therapeutic compounds
GB0509405D0 (en) Therapeutic compounds
GB0606663D0 (en) Therapeutic compounds
GB0513747D0 (en) Therapeutic compounds
GB0615809D0 (en) Therapeutic compounds
GB0612971D0 (en) Therapeutic compounds
GB0522130D0 (en) Therapeutic compounds
GB0526107D0 (en) Therapeutic Compounds
GB0625349D0 (en) Therapeutic compounds
GB0518235D0 (en) Therapeutic compounds
EP2079704A4 (en) THERAPEUTIC COMPOUNDS
GB0625345D0 (en) Therapeutic compounds
ZA200804266B (en) Therapeutic uses of steroidal compounds
GB0605573D0 (en) Therapeutic Compounds
GB0603455D0 (en) Therapeutic compounds